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Background: In both beef and dairy cattle, the majority of early embryo loss occurs within the first 14 days following
insemination. During this time-period, embryos are completely dependent on their maternal uterine environment for
development, growth and ultimately survival, therefore an optimum uterine environment is critical to their survival. The
objective of this study was to investigate whether differences in endometrial gene expression during the mid-luteal
phase of the estrous cycle exist between crossbred beef heifers ranked as either high (HF) or low fertility (LF) (following
four rounds of artificial insemination (AI)) using the Affymetrix® 23 K Bovine Gene Chip.
Results: Conception rates for each of the four rounds of AI were within a normal range: 70–73.3%. Microarray analysis
of endometrial tissue collected on day 7 of the estrous cycle detected 419 differentially expressed genes (DEG)
between HF (n = 6) and LF (n = 6) animals. The main gene pathways affected were, cellular growth and proliferation,
angiogenesis, lipid metabolism, cellular and tissue morphology and development, inflammation and metabolic
exchange. DEG included, FST, SLC45A2, MMP19, FADS1 and GALNT6.
Conclusions: This study highlights, some of the molecular mechanisms potentially controlling uterine endometrial
function during the mid-luteal phase of the estrous cycle, which may contribute to uterine endometrial mediated
impaired fertility in cattle. Differentially expressed genes are potential candidate genes for the identification of genetic
variation influencing cow fertility, which may be incorporated into future breeding programmes.Background
The failure of breeding females to become pregnant, in
both dairy and beef cattle production systems, directly
impacts the economic viability of these enterprises, and
ultimately hinders genetic progress. Significant decreases
in dairy cow fertility, ranging from 0.45% to 1% per annum,
have been reported in cattle populations across the globe
[1-3]. Following insemination the greatest increment of
cow reproductive wastage occurs in the form of early em-
bryo mortality with approximately 80% of this occurring
within 14–16 days [4-6]. More specifically, previous studies
have highlighted that the majority of early embryo loss
typically commences around the mid-luteal phase of an
estrous cycle i.e. day 7 of pregnancy [7,8] concurrent with
the critical blastulation stage of embryo development [9].* Correspondence: sinead.waters@teagasc.ie
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reproduction in any medium, provided the orThere is evidence of repeatable differences between cows
in their ability to become pregnant. McMillan [10] reported
a 65% difference in pregnancy rate at 60 days of gestation,
following 6 consecutive in vitro embryo transfer events, be-
tween two groups of cows. Differences in follicle wave dy-
namics, duration of estrus, site of ovulation, or subsequent
progesterone profiles were not found to contribute to the
observed difference in pregnancy rate. Indeed, the authors
suggested that “uterine” rather than “ovarian” factors may
be responsible for the variation observed. This uterine ef-
fect was also hypothesized in similar studies examining
phenotypic differences between high and low fertility ani-
mals [11-13]. Furthermore, data from our laboratory sug-
gest a repeatability estimate of 0.18 for embryo survival in
beef heifers [13] and heritability estimates for conception
rate have been reported to exceed 0.20 [14,15].
The prerequisites to the establishment and mainten-
ance of a successful pregnancy include a viable embryo,
an appropriate steroidal environment and an optimallyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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metrium plays a pivotal role in orchestrating the events
that lead to fertilization, implantation and pregnancy.
Throughout the estrous cycle and pregnancy, the endomet-
rium is subjected to a host of functional and morphological
changes, regulated by the hormones progesterone, estradiol
and oxytocin [19]. The endometrium also functions to
secrete a multitude of growth factors, proteins and cyto-
kines, all of which constitute the histotroph, an import-
ant source of energy and nutrition to a growing embryo
in vivo [20-22].
Using conventional candidate approaches many stud-
ies have examined bovine endometrial gene expression
under various conditions; during early pregnancy in ani-
mals that produced viable and non-viable embryos [23],
in pregnant and cycling animals with artificially induced
high, and normal systemic progesterone concentrations
[24-26] and during the various phases of the estrous cycle
[27]. Furthermore global endometrial gene expression ana-
lyses have been conducted and include comparisons be-
tween cycling and pregnant animals [28,29], fertile and sub-
fertile animal strains [30,31], progesterone supplementation
treatments [32], and specific estrous cycle phases [33,34].
Despite these efforts, endometrial gene expression of ani-
mals characterized as either high or low fertility has not
been investigated. Given the critical importance of day 7
[7,8], we hypothesise that uterine endometrial gene expres-
sion patterns will be different between high and low fertility
heifers on day 7 of the estrous cycle. Thus, the objective of
this study was to characterize differential gene expression
profiles in endometrial tissue harvested on day 7 of the es-
trous cycle from heifers ranked as either HF or LF fertility
based on four successive inseminations and pregnancy
diagnoses. Intercaruncular endometrial tissue was exam-
ined due to the fact that caruncular endometrium lacks
uterine glands which are essential to the exchange, trans-
port and secretion of pertinent metabolites which consti-
tute the uterine histoptroph and are required to support
pregnancy [35,36].
Methods
Ethics statement
All experimental procedures involving heifers were li-
censed by the Department of Health and Children, Ireland
(licence number B100/846). Protocols were in accordance
with the Cruelty to Animals Act (Ireland 1876, as amended
by European Communities regulations 2002 and 2005)
and the European Community Directive 86/609/EC and
were sanctioned by the Institutional Animal Research
Ethics Committee.
Animal model
Estrous cycles of reproductively normal nulliparous cross-
bred beef heifers (Bos taurus n = 120) were synchronizedusing two intramuscular administrations of 500 μg
of the prostaglandin F2α analogue (PG), cloprostenol
(Estrumate®, Schering-Plough Ltd., Shire Park, Welwyn
Garden City, Hertfordshire, UK). Animals were visually
observed for signs of estrous activity 3- to 5- times daily
as described by Lynch et al. [7]. Only heifers observed to
be in standing estrus were inseminated 6–18 hrs after on-
set of heat [37]. Inseminations were carried out artificially
by one trained technician. Heifers were given a single
insemination of frozen-thawed semen, collected from a
single ejaculate of one high fertility bull. Sire breed was
Limousin and named Bolide (FL17). At the time of the 1st
insemination, heifers were on average 20 months of age
and weighed 440 ± 9.0 kg (Mean ± SEM).
Using an Aloka SSD-500 V ultrasound scanner, fitted
with a 7.5 MHZ transducer (Aloka Co. Ltd., Tokyo, Japan),
pregnancy was diagnosed 28 days after insemination using
the criteria set out by Kastelic et al. [38]. Following diag-
nosis, all pregnant heifers received PG on day 28 to induce
embryo loss. Six weeks after induced embryo loss all
heifers were subjected to estrous reprogramming using a
two-injection PG-regimen (11 days apart), inseminated
and pregnancy scanned as described above.
For the purpose of establishing an accurate high versus
low heifer fertility model, this schedule was followed for
a further two occasions. Thus, following four insemina-
tions, animals that established a pregnancy on all four
occasions were categorized as “HF” heifers while those
achieving pregnancy on only one occasion were catego-
rized as “LF” heifers. To eliminate the possibility of a phys-
ical or anatomical abnormality that may have impeded
heifers from becoming pregnant, animals with zero re-
corded pregnancies were omitted from the study.
After the fourth insemination, and subsequent pregnancy
diagnosis, pregnant heifers were returned to estrous. Ap-
proximately three months later, estrous cycles of animals
were synchronized again in preparation for endometrial
harvesting on D7. Figure 1 illustrates the timeline of events
during the experimental period.
Throughout the experimental period, animals had ad
libitum access to grass silage supplemented with 2 kg of
concentrates per heifer per day. Heifers were housed on
concrete slats in groups of 15, at 2.5 m2 per heifer, for
the duration of the study (15 months). Slaughter live-
weight averaged 625 kg, with BCS of 4.0. Heifers were
gaining weight during the course of inseminations in the
region of 0.60 kg/day.
Tissue sampling
Animals from HF (n = 6) and LF groups (n = 6) were
slaughtered on D7 in a licensed abattoir (KEPAK,
Athleague, Co. Roscommon, Ireland). Following slaughter
the reproductive tract and ovaries were checked for gross
abnormalities but none were recorded. Uterine tissues
Figure 1 Experimental design timeline.
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Intercaruncular endometrial cross-sections approximately
4 sq cm, and weighing 2.5 g, were harvested from the ani-
mals by peeling from the underlying uterine myometrium
from the middle-third of the uterine horn ipsilateral to the
corpus luteum (CL) within 20 min of slaughter.
Samples were washed in sterile PBS, and stored in
RNAlater® at 4°C for 24 h before being transferred for long-
term storage at −20°C. All surgical instruments used for tis-
sue collection were sterilized and treated with RNA Zap
(Ambion, Applera Ireland, Dublin, Ireland). In addition, on
the day of slaughter CL diameter for each heifer was deter-
mined using vernier calipers.
Blood sampling
Heifers were blood sampled via jugular venipuncture for
subsequent measurement of progesterone at 0900 and
2100 h commencing 24 h after PG for a cycle length. All
blood samples were collected into 10 ml ethylenediamine
tetraacetic acid (EDTA) heparinized Vacutainers (Becton
Dickson Vacutainer Systems, Plymouth, UK). Samples were
held in iced water until centrifuged at 1500 × g at 4°C for
15 mins after which plasma was extracted and stored in
sterile 7 ml vials at −20°C until assayed.
Progesterone assays
Progesterone profiles for each of the six heifers within
HF and LF groups were established. Concentration of
progesterone was measured in plasma as the mean of
the two samples taken on each cycle day of the previous
cycle and on 7 days prior to slaughter using the Coat-a-
Count assay procedure (Coat-a-Count Diagnostic Products
Corporation, Los Angeles, CA, USA) with each sample
tested in duplicate. The inter-assay and intra-assay coeffi-
cients of variation for low, medium and high controlsamples were 17.4% and 4.4%, 5.6% and 28.4%, and 4.2%
and 4.9% with mean concentrations of 0.24, 2.54 and
7.21 ng/mL, respectively. The minimum detectable limit
for this assay was 0.06 ng/mL.
RNA extraction and quality analysis
Total RNA was prepared from 100–200 mg of endometrial
tissue using the TRIzol reagent (Sigma-Aldrich Ireland
Ltd., Dublin, Ireland). Tissue samples were homogenized
in 3 ml of TRIzol reagent and chloroform, and subse-
quently precipitated using isopropanol (Sigma-Aldrich
Ireland Ltd., Dublin, Ireland). RNA samples were stored
at −80°C. Samples of RNA, (20 μg), were purified and
treated for contaminating genomic DNA using RNeasy
clean-up kits in accordance with manufacturer’s guide-
lines supplied (QIAGEN, Crawley, West Sussex, UK).
This protocol included an on-column DNase treatment
step. RNA quality and quantity were assessed using auto-
mated capillary gel electrophoresis on a Bioanalyzer 2100
with RNA 6000 Nano Lab-chips according to manufac-
turer’s instructions (Agilent Technologies Ireland, Dublin,
Ireland). Absorbance ratios (28S/18S) and RNA integrity
values recorded for all RNA samples extracted post
clean-up ranged between 1.8 and 2.0, and 7.5 and 9.8,
respectively.
Microarray hybridization
Gene expression was determined using a 24,027 probe
set bovine oligonucleotide array (Affymetrix®), represent-
ing ~23,000 bovine transcripts based on the original
mapping using Unigene build 57 (March 24, 2004). RNA
from each heifer was hybridized to a separate array. All 12
RNA samples were hybridized and scanned by the German
Resource Centre for Genomic Research (RZPD), Germany,
according to the manufacturer’s instructions.
Killeen et al. BMC Genomics 2014, 15:234 Page 4 of 18
http://www.biomedcentral.com/1471-2164/15/234Microarray analysis
All microarray analyses including preprocessing, normal-
ization and statistical analysis were carried out using R
(R, 2007) version 2.6 and Bioconductor [39] version 2.1 as
previously described by [40]. Data were quality assessed
before and after normalization using a number of in-built
quality control methods implemented in the Bioconductor
affycoretools and associated packages to identify problems
if they existed with array hybridization, RNA degradation
and data normalization. Microarray data were prepro-
cessed using the mmgMOS normalization method [41,42]
using the default settings and differential expression (DE)
was calculated using the pumaDE method both imple-
mented in the Bioconductor package “puma” [42-45]. The
puma method uses a Bayesian hierarchical model to
calculate the probability of positive likelihood ratio
(PPLR). The PPLR associates probability values of genes
being differentially expressed, which is a measure of false
positive detection of DE, to each ratio and generates lists
of genes ranked by the probability of DE. This PPLR
statistic was converted into “P-like values” using the
recommended formula in the puma method prior to sub-
sequent analysis.
As many of the original annotations for the Affymetrix
bovine chip are erroneous [6,46], remapped annotations
were determined using the “bovinedaiplusv6cdf” chip def-
inition file (CDF). This annotation is based on the CDF-
Merger procedure as described by De Leeuw et al. [47],
which generates a hybrid CDF based on the standard Affy-
metrix CDF (version 26) and the custom Brainarray (ver-
sion 11.0.1) CDF. This re-mapped annotation includes
mapping to all RefSeq (mature RNA protein coding
transcripts and validated complete coding sequences in
GenBank). Annotations were also supplemented by inter-
rogating the Ensembl Bos taurus database version 46 using
the BioMart package in Bioconductor and manual annota-
tion where possible with recent entries in Entrez Gene.
Pathway analysis
To examine the molecular functions and genetic net-
works, the microarray data were further analyzed using
Ingenuity Pathway Analysis (v. 8.8, Ingenuity Systems,
Mountain View, CA; http://www.ingenuity.com), a web-
based software application that enables identification of
over-represented biological mechanisms, pathways, and
functions most relevant to experimental datasets or genes
of interest [40,48-50].
A dataset containing gene identifiers and corresponding
expression and P-like values was uploaded into IPA. Briefly,
each identifier was mapped to its corresponding gene
object in the Ingenuity knowledge base. A P-like value
of P < 0.05 from the puma analysis was set to identify
genes whose expression was statistically significantly
up- or down-regulated. These genes, called “focus” genes,were overlaid onto a global molecular network developed
from information contained within the Ingenuity know-
ledge base. Networks of these focus genes were then al-
gorithmically generated based on their connectivity.
Network analysis returns a score that ranks networks
according to their degree of relevance to the network
eligible molecules in the dataset. The score takes into
account the number of network eligible molecules in
the network and its size, as well as the total number of
network eligible molecules analyzed and the total num-
ber of molecules in the knowledge base that could po-
tentially be included in networks.
RT-qPCR analysis
The microarray results were validated by carrying out
RT-qPCR on 18 genes. Candidate genes were chosen
based on the following criteria; those that were top rank-
ing in our microarray DEG list, genes with known func-
tional importance in uterine mediated sub-fertility which
were either up- or down-regulated and genes which
were not differentially expressed between the two treat-
ment groups.
Using the same RNA samples that were analyzed in
the microarray studies, first strand cDNA was synthe-
sized using the High Capacity cDNA Reverse Transcrip-
tion kit according to manufacturer’s instructions (Applied
Biosciences, Ireland). Purified total RNA (1 μg) was re-
verse transcribed using random hexamers. The converted
cDNA was quantified by absorbance at 260 nm, diluted to
50 ng/μl working stocks and stored at −20°C, for subse-
quent analyses.
Analysis of putative reference genes for RT-qPCR stud-
ies was carried out using GeNorm version 3.5 Microsoft
Excel Add in (Microsoft, Redmond, WA) [51]. The stabil-
ity of the expression of several cited reference genes in-
cluding, ribosomal protein L15 [52], 18 s ribosomal RNA
[53], ubiquitin [54], glyceraldehyde phosphate dehydro-
genase and β-actin [55,56], was investigated across all
samples in this study. Similar to Coyne et al. [54], ubiqui-
tin (at an optimal concentration of 2.5 μM) exhibited the
greatest stability during qPCR analysis of endometrial
mRNA samples analyzed, with an M value of 0.022. Based
on a recommended cut-off V value of 0.15; ubiquitin was
selected as a single standard reference gene for these ex-
periments as the use of additional reference genes did not
contribute to a more accurate normalization factor.
Primers were designed, to span exon boundaries where
possible, using the Primer3 software programme [57]
and oligos were aligned by Basic Local Alignment Search
Tool (BLASTN) on the National Centre for Biotechnol-
ogy Information (NCBI) web page, to verify their identity
and homology to the bovine genome (http://www.ncbi.
nlm.nih.gov/BLAST/). All oligonucleotides were commer-
cially synthesized as highly purified salt-free products by
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end point PCR to optimize amplification conditions. All
amplified PCR products generated in this study were
purified using the PCR purification kit (Roche, Basel,
Switzerland) and sequenced (Macrogen; Nucleics Pty
Ltd, Bendigo, Australia) to verify their identity. Primer
sequences used in this study are listed in Table 1.
Primer concentrations were optimized for each gene
by titrating 5, 10, and 20 μM per primer. The most suit-
able primer concentration was chosen based on four cri-
teria in order of decreasing importance: i) a clear distinct
melt curve absent of any additional peak(s) caused by
non-specific binding, ii) a curve within the temperature
range 75–85°C, iii) the primer concentration producing
the lowest threshold cycle number (Ct) and lastly, iv) repli-
cation amongst Ct values and melting temperatures (Tm).
Subsequently, efficiencies of chosen primer concentrations
were determined over a 5-fold dilution series, whereby
cDNA was diluted into working solutions: stock, 1:2, 1:4,
1:8, 1:16, and RT-qPCR assays carried out. This was re-
peated for every gene. The r2 and amplification efficiency
(E) values for RT-qPCR were calculated from linear re-
gression analysis of log (input cDNA) versus Ct plot. The
slope for each set of standards was used to determine E =
10(−1/slope) – 1. Slopes, amplification efficiencies and R2
estimates for individual genes are reported in Table 2.
Only primers with PCR efficiencies between 90% and
110% were used.
Each RT-qPCR reaction was carried out in a 96-well
plate format with a total volume of 20 μl, containing
1 μl cDNA, (10 ng/μl), 10 μl Fast SYBR® Green Master
Mix (Applied Biosystems, Ireland), 1 μl forward and reverse
primers and 8 μl nuclease-free H2O. Performance of RT-
qPCR was carried out using the Applied Biosystems Fast
7500 v2.0.1 with the following cycling parameters: 95°C for
10 min followed by 40 cycles of 95°C for 15 s and 60°C for
60 s, followed by amplicon dissociation (95°C for 15 s, 60°C
for 60 s, 95°C for 15 s and 60°C for 15 s). Dissociation
curves were examined for the presence of a single PCR
product. The software package GenEx 5.2.1.3 (MultiD Ana-
lyses AB, Gothenburg, Sweden) was used for efficiency
correction of the raw cycle threshold (Ct) values, inter-
plate calibration based on a calibrator sample included
on all plates, averaging of replicates, normalization to
the reference gene and the calculation of quantities
relative to the greatest Ct. Expression of each target
gene was normalised to the reference gene and relative
differences in gene expression were calculated using the
2-ΔΔCT method [58].
Statistical analysis
All data were analyzed using the Statistical Analysis Sys-
tems software package (SAS Inst. Inc., Cary, NC) version
9.1. Data from RT-qPCR studies were tested for adherenceto normality using PROC UNIVARIATE (SAS, 2003).
Non-normal data were subsequently transformed using
the best fit function as described by PROC TRANSREG
(SAS, 2003). Differences in mean values between the two
groups (HF and LF) were tested using ANOVA (PROC
MIXED). Animal within treatment was used as the error
term. The Tukey critical difference test was used to deter-
mine statistical difference between LF and HF mean values.
The CORR procedure of SAS (PROC CORR, SAS 2003) was
used to determine correlations between microarray and RT-
qPCR data. Pearson correlation coefficients were estimated
for each individual gene across all animals (n = 12). A P value
of P< 0.05 was considered to be statistically significant. Data
collected from CL diameter measurements were tested for
adherence to normality using PROC UNIVARIATE (SAS,
2003). CL differences in mean values between the two
groups (HF and LF) were tested using ANOVA (PROC
MIXED). Animal within treatment was used as the error
term. For the analysis of progesterone profiles individual
profiles were normalized relative to day of estrus (Day 0).
The effect of fertility status “HF” versus “LF” was established
using a repeated measured analysis (PROCMIXED; SAS).
Results
Animal model
Embryo survival rates were 73.3%, 71.7%, 73.3% and
70.0% for A.I. rounds 1, 2, 3 and 4 respectively. A total
of 31 heifers qualified as HF or LF; 15 HF and 16 LF, of
which three of these were eliminated from the study due
to the presence of ovarian abnormalities detected at
ultrasound scanning. Pregnancy rate for LF heifers was
consistent across all four replicates. Six HF and 6 LF heifers
were randomly chosen within their respective fertility
groups for slaughter on D7. The mean inter-estrous inter-
vals in a previous recorded estrous cycle were 20.17 ± 0.96
and 20.83 ± 0.96 days (P > 0.10) for the HF and LF heifers,
respectively. At day of slaughter, mean CL diameters were
22.58 ± 3.48 (SD) mm and 23.55 ± 4.4 (SD) mm for HF and
LF heifers, respectively, i.e., there was no significant differ-
ence in CL diameter between fertility groups (P > 0.10).
Progesterone profiles
There was no effect of fertility status, or interaction effect
of fertility status and day of cycle (P > 0.10), on the concen-
tration of progesterone. On the day of slaughter plasma
concentrations did not differ between the high and low fer-
tility groups (HF 5.96 ng ml−1; LF 5.65 ng ml−1, P = 0.589).
Microarray differential gene expression
A total of 419 genes were found to be differentially
expressed between LF and HF (n = 6 vs. 6). Of these, 171
were up-regulated and 248 down-regulated in the LF com-
pared with HF heifers, respectively. Transcript abundance
differences between LF and HF groups resulted in fold
Table 1 Bovine specific oligonucleotide forward and reverse primer sequences (5′-3′) and PCR product length
Gene name Sequence Accession number Amplicon size (bp)
18S/28S F: 5′- TGCTCTCGCAAACCTAACCT-3′ DQ222453 159
R: 5′- CACTAAGCACTCGCATTCCA-3′
ACTA2 F: 5′- ACTGGGACGACATGGAAAAG -3′ BT021508 166
R: 5′- TACATGGCTGGGACATTGAA-3′
ACTB F: 5′- ACTTGCGCAGAAAACGAGAT-3′ BT030480 121
R: 5′-CACCTTCACCGTTCCAGTTT-3′
APEH F: 5′- CAAGAGCATGCGCAGTATGT -3′ BC123400 181
R: 5′- GTAGAGCTGCAAAGCCCATC-3′
CELA1 F: 5′- GGAACCATCCTGGCTAACAA -3′ BC149525 165
R: 5′- CATGGTGGTCTTCACAGTGG -3′
DONSON F: 5′- TGTGTTGGTGAAGGGAATGA -3′ BC133573.1 107
R: 5′- AGAGGGTTGGTGGAAGTCCT -3′
FST F: 5′- TAAATGAGAGACCCGCCAAC-3′ AY775795 171
R: 5′- CCCCAGTTTCTGTCCTGTGT-3′
GALNT6 F: 5′- GACCACGTCTTGGACCTCAT-3′ NM_001015534 146
R: 5′- AGCTCAGCTGGGGTGTAGAA-3′
GAPDH F: 5′- GGGTCATCATCTCTGCACCT-3′ NM_001034034 176
R: 5′- GGTCATAAGTCCCTCCACGA-3′
GJA1 F: 5′- - CAACATGGGTGACTGGAGTG 3′ BT021508 110
R: 5′- GCAGGATTCGGAAAATGAAA -3′
IL33 F: 5′- TTGTTTTGGAGGATGGAAGC -3′ BC123562 163
R: 5′- TTTGTGGGGCTCAGGTTTAC -3′
MMP19 F: 5′- TGGACGTTATCCCCTCAGTC-3′ BC123722 119
R: 5′- GTCCATGGTTCATGCTTGTG -3′
MOSC2 F: 5′- GCAGTGCTTTTGAGGAGGAC-3′ NM_001076380 169
R: 5′- GGATCACACAGGCGGTAACT-3′
NMB F: 5′- ACATGACGACATGGCTGAAA-3′ NM_001075270 185
R: 5′- ACTTCAACAGGGAAGCGAGA-3′
NPPC F: 5′- GAGGCAACAAGAAGGGTTTG -3′ BC123399 149
R: 5′- CTGATGACCAAGGGTGACCT -3′
PPARA F: 5′- TTGTGGCTGCTATCATTTGC-3′ AF229356 135
R: 5′- AGAGGAAGACGTCGTCAGGA-3′
RAB3B F: 5′- TGGGCGGAGATTCATTTTAC -3′ BC112795 144
R: 5′- GAAAAGTGTGCATGGGTGTG -3′
RPL15 F: 5′- TGCATAAGCACAGGGAGATG-3′ BT020706 134
R: 5′-CTGGAGAGTATTGCGCCTTC-3′
SFRP1 F: 5′- GTCCCTCTGGGTGAATCTGA-3′ NM_174460 158
R: 5′- TCACTAATTGCCAGGGGTTC-3′
SLC1A3 F: 5′-CATCCATGCTGTCATTGTCC-3′ BC120125 188
R: 5′-ATCTGGTAACGCGTTTGTCC -3′
SLC45A2 F: 5′- CATGCCCTCTTCACAGGTTT-3′ XM_001251343 179
R: 5′- AGTGGGGCTTCAGGGATACT -3′
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Table 1 Bovine specific oligonucleotide forward and reverse primer sequences (5′-3′) and PCR product length
(Continued)
TGFB1I1 F: 5′- CCTGCAATAAACCCATTGCT-3′ NM_001035313 162
R: 5′- AGAAGCGCTCGAAGTAGCAC-3′
UBQ F: 5′- TACAACAGTTGGTGGCCAAA-3′ BC102888 121
R: 5′-GAAGACTGGGCTGACTGAGG-3′
18S/28S, 18S/28S ribosomal RNA; ACTA2, actin alpha 2; ACTB, beta-actin; APEH, N-acylaminoacyl-peptide Hydrolase; CELA1, chymotrypsin-like elastase family mem-
ber 1; DONSON, downstream neighbor of SON; FST, follistatin; GALNT6, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GJA1, gap junction protein, alpha 1; IL33, interleukin 33; MMP19, matrix metallopeptidase 19; MOSC2, MOCO
sulphurase C-terminal domain containing 2; NMB, neuromedin B; NPPC, natriuretic peptide C; PPARA, peroxisome proliferator-activated receptor alpha; RAB3B,
RAB3B member ras oncogene family; RPL15, ribosomal protein L15; SFRP1, secreted frizzled-related protein 1; SLC1A3, solute carrier family 1 member 3; SLC45A2,
solute carrier family 45 member 2; TGFB1I1, transforming growth factor beta 1 induced transcript 1; UBQ, ubiquitin.
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in LF animals. The microarray data have been deposited in
NCBI’s Gene Expression Omnibus [59] and are accessible
through GEO Series accession number GSE29853. Hier-
archical clustering of differentailly expressed genes is pre-
sented as a heatmap and dendogram in Additional file 1:
Figure S1.Pathway analysis
Of the 419 DEG, a total of 227 genes were successfully
mapped to a molecular/biological pathway and/or cat-
egory in the IPA database, while 202 of these were net-
work eligible using IPA. Among the mapped DEG, 73
were up-regulated (Additional file 2: Table S1) and 154
down regulated (Additional file 2: Table S2).Table 2 Efficiency variables for individual RT-qPCR genes
Gene Optimum [primer] μM Slope (−) R2 Efficiency
ACTA2 5 3.62 0.99 1.890
APEH 20 3.18 0.99 2.064
CELA1 10 3.54 0.99 1.917
DONSON 10 3.20 0.99 2.054
FST 2.5 3.60 0.97 1.896
GALNT6 5 3.29 0.99 2.103
GJA1 20 3.31 0.98 2.003
IL33 5 3.33 0.96 1.997
MMP19 10 3.52 0.99 1.925
MOSC2 10 3.14 0.99 2.082
NMB 10 3.21 0.99 2.049
NPPC 5 3.63 0.99 1.885
PPARA 5 3.33 0.99 1.997
RAB3B 20 3.51 0.99 1.927
SFRP1 5 3.70 0.97 1.863
SLC1A3 10 3.46 0.97 1.946
SLC45A2 10 3.54 0.95 1.916
TGFB1I1 20 3.29 0.96 2.013
UBQ 2.5 3.20 0.99 2.054Biological functions
Biological categories with the largest number of up regu-
lated genes included DNA replication, recombination and
repair, nucleic acid metabolism and carbohydrate metabol-
ism. Categories with the largest number of down-regulated
genes were organ morphology, and connective tissue de-
velopment and function. Of the top 20 most statistically
significantly over-represented biological categories, DNA
replication, recombination and repair had the greatest ratio
of up- to down-regulated genes (Figure 2). Pathways with
the greatest number of DEG, including their respective
number of DEG, were cellular growth and proliferation
(n = 57), inflammatory disease (n = 55), cell death (n = 49),
cellular development (n = 43), small molecule biochemis-
try (n = 37), cellular morphology (n = 36) and tissue devel-
opment (n = 36) as shown in Table 3.
Canonical pathways
Canonical signaling pathway analysis uncovered genes
with functions in ILK-signaling, TR/RXR activation, regu-
lation of actin based motility by Rho and Integrin signaling
(Table 4). Genes associated with canonical signaling path-
ways were down-regulated in LF animals for all statistically
significant pathways mapped with the exception of TR/
RXR activation where the ratio of up- to down-regulated
genes was uniform. Canonical metabolic pathways over-
represented within the microarray data included fatty acid
biosynthesis, o-glycan biosynthesis and purine metabolism.
There were more genes up-regulated in canonical meta-
bolic than canonical signaling pathways with the greatest
ratio of up- to down-regulated genes expressed in the
metabolic pathway: o-glycan biosynthesis (Table 4).
Networks
Using IPA a total of 19 gene networks were identified, 12
of which had 13 to 25 focus genes among DEG (Additional
file 2: Tables S1 and S2). The 12 top networks are listed in
Table 5. Lipid metabolism featured in three of the top 12
networks. In addition, organ/tissue/cell morphology and
development appeared a central biological theme over-
represented among DEG. Illustrations of gene interac-
tions among DEG contained within the top two scoring
Tissue Development
Cell Morphology
Small Molecule Biochemistry
Nucleic Acid Metabolism
Molecular Transport
DNA Replication, Recombination, & Repair
Cellular Development
Hepatic System Development & Function
Connective Tissue Development & Function
Organ Morphology
Organ Development
Skin Development and Function
Cell Death
Dermatological Diseases & Conditions
Cellular Growth & Proliferation
Carbohydrate Metabolism
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Skeletal & Muscular System Development & Function
Endocrine System Development & Function
Tumor Morphology
Gene Expression
Figure 2 Classification of DEG according to top 20 molecular and cellular functions, most significantly affected by endometrial related
sub-fertility, using IPA. The red/green bars indicate the likelihood [−log (P-value)] that the specific molecular and cellular function category was
affected by endometrial related sub-fertility compared with others represented in the list of DEG. The proportion of up- and down-regulated genes in
each group is represented by the red and green segments on each bar, respectively.
Table 3 Biological categories from IPA analysis with the largest number of DEG
Biological category Gene symbol
Cellular growth and proliferation ACTB, ADCY3, CAT, CD58, CIAO1, CNOT8, COL1A2, CTSL2, CXCL2, CTSL2, DAP, DCK, EMP3, ENPP1, ETFDH, FASN,
FHL2, FST, FUS, GADD45B, GJA1, GLI3, HMGB1, IL6ST, ILF3, IMPDH2, LGALS1, LGALS3, LTBP1, LY6E, MAGED1,
MAP3K7IP2, MEST, MMP19, NMB, ODC1, PARK7, PPARA, PHLDA1, PPARA, PRKRA, PRMT1, PSMB10, PSMD2, PTPRK,
RBBP7, SERPINH1, SFRP1, SLC1A3, SOX6, TCF12, TGFB1I1, TOB2, TP53I11, UCP3, WFDC1, ZNF259
Inflammatory disease ACTA2, ACTB, ADCY2, ADCY3, APEH, C1QTNF6, CACNB2, CAT, CD58, CORO2A, CXCL2, DAP, DCK, DSC2, EEF2,
ENPP1, FAU, FNBP1, GADD45B, GALNT2, GLI3, GLUL, GSDMB, HMGB1, IFI6, IL33, IL6ST, IMPDH2, LGALS1, LGALS3,
LPHN2, LTBP1, MYLK, NSF, ODC1, ORC5L, PARP4, PCMTD1, PPARA, PRMT1, PTGIS, PTPRK, RAB12, RARRES2,
RGNEF, RPS3, SCG5, SLC1A3, SLC25A24, SLC45A2, SOX6, SRPK2, TCF12, TNIK, WFDC1
Cell death ACTB, ACTC1, BAG3, CACNB2, CAT, CTSL2, CXCL2, DAP, EMP3, FASN, FAU, FHL2, FST, FUS, GADD45B, GALNT2, GIMAP5,
GJA1, GLI3, HMGB1, HSPB1, IFI6, IL6ST, LGALS1, LGALS3, LTBP1, MAGED1, MAP3K7IP2, MYLK, NPPC, NSF, ODC1, PARK7,
PARP4, PHLDA1, PPARA, PRKRA, PTGIS, QKI, RCAN2, RPS3, SCG5, SFRP1, SLC1A3, SLC25A24, SOX6, SRPK2, TCF12, TGFB1I1
Cellular development ARHGDIG, ARHGEF11, BOC, CAT, CTSL2, CXCL2, ENPP1, FHL2, FHL3, FLNC, FST, FUS, GADD45B, GEFT, GIMAP5,
GJA1, GLI3, HMGB1, IL33, IL6ST, LGALS1, LGALS3, LTBP1, MAGED1, MARCKS, MYLK, NPPC, NR0B1, ODC1, PPARA,
QKI, RARRES2, RCAN2, RNF128, SFRP1, SLC1A3, SMOC2, SOX6, STIM1, TCF12, TGFB1I1, TNIK, TOB2
Small molecule biochemistry ACAT1, ANKRD26, CAT, CMPK1, DCK, ERH, ETFDH, FASN, FST, GALNT2, GJA1, GLUL, HMGB1, IL6ST, LGALS1, LRAT,
MARCKS, NMB, NPPC, ODC1, PAICS, PARK7, PCCB, PPARA, PRMT1, PTGIS, QKI, RAB3B, SCG5, SLC1A3, SLC25A12,
SOX6, SRD5A1, SULT1A1, SV2A, TGFB1I1, UCP3
Cell morphology ACTA2, ACTC1, ANXA6, ARHGDIG, ARHGEF11, CTSL2, CXCL2, DPYSL3, ENPP1, FASN, FERMT2, FHL3, FLNC, FST,
GJA1, HMGB1, HSPB1, IL6ST, LGALS1, LGALS3, LRAT, MARCKS, NPPC, NTN4, ODC1, PHLDA1, PPARA, RGNEF,
RNF128, SCG5, SERPINH1, SFRP1, SLC1A3, SOX6, TGFB1I1, TNIK
Tissue development ACTA2, ACTC1, ALX1, ARHGDIG, BOC, CAT, CD58, COL16A1, CXCL2, DSC2, ENPP1, FASN, FHL3, GADD45B, GEFT,
GJA1, GLI3, HMGB1, IL33, IL6ST, LGALS3, LY6E, MARCKS, MEST, MMP19, NPPC, NR0B1, NTN4, PHLDA1, PPARA,
PTPRK, SEMA5A, SFRP1, SOX6, TCF12, TGFB1I1
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Table 4 Enriched canonical pathways in endometrial mRNA from HF and LF heifers
Pathways Genes % DEG P-value
Canonical signalling
Regulation of Actin-based Motility by Rho MYLK, ACTB, ACTA2, RHOU, ACTC1, FNBP 6.5 0.0007
ILK Signalling TGFB1I1, FLNC, ACTN2, ACTB, ACTA2, FERMT2, RHOU, ACTC1, FNBP1 4.3 0.0017
Caveolar-mediated Endocytosis Signalling FLNC, ACTB, ACTA2, ACTC1, COPB2 6.0 0.0024
Polyamine Regulation in Colon Cancer PSMD11, PSMB10, PSMD2, ODC1 7.0 0.0041
Cellular Effects of Sildenafil MYLK, ADCY2, ACTB, ACTA2, ADCY3, ACTC1 3.9 0.0068
RhoA Signalling MYLK, ACTB, ACTA2, ARHGEF11, ACTC1 4.5 0.0126
Mechanisms of Viral Exit from Host Cells ACTB, ACTA2, ACTC1 6.8 0.0135
TR/RXR Activation UCP3, RAB3B, FASN, RCAN2 4.1 0.0245
Virus Entry via Endocytic Pathways FLNC, ACTB, ACTA2, ACTC1 4.2 0.0245
Semaphorin Signalling in Neurons DPYSL3, RHOU, FNBP1 5.8 0.0288
HMGB1 Signalling HMGB1 (includes EG:3146), RBBP7, RHOU, FNBP1 4.1 0.0302
Thrombin Signalling MYLK, ADCY2, ADCY3, RHOU, ARHGEF11, FNBP1 2.9 0.0331
Integrin Signalling MYLK, ACTB, ACTA2, RHOU, ACTC1, FNBP1 3.0 0.0331
Sphingosine-1-phosphate Signalling ADCY2, ADCY3, RHOU, FNBP1 3.6 0.0407
Germ Cell-Sertoli Cell Junction Signalling ACTB, ACTA2, RHOU, ACTC1, FNBP1 3.2 0.0417
CXCR4 Signalling ADCY2, ADCY3, RHOU, ARHGEF11, FNBP1 3.0 0.0447
Canonical metabolic
Purine Metabolism NSF, ADCY2, ENPP1, IMPDH2, DCK, ATP13A5, ADCY3,
PDE6C, PAICS, POLR2H, ACTC1
2.5 0.0019
Glycan Biosynthesis GALNT2, GYLTL1B, GALNT6 6.3 0.0077
Fatty Acid Biosynthesis FASN, PCCB 3.9 0.0098
Sulphur Metabolism SULT1A1, SUOX 3.3 0.0316
Pantothenate and CoA Biosynthesis ENPP1, DPYSL3 3.1 0.0347
Pyrimidine Metabolism ENPP1, DCK, DPYSL3, POLR2H, CMPK1 2.2 0.0457
Genes marked in bold are up-regulated.
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ways; lipid metabolism, cell growth and proliferation, and
tissue development and function, were repeatedly featured
pathways that constituted these top scoring networks.
RT-qPCR analysis
Eighteen genes were validated by real-time RT-qPCR
(Table 1). There was moderate to good consistency be-
tween methodologies for direction and magnitude of differ-
ential gene expression among genes analyzed. Correlation
coefficients exceeded 0.60 in fourteen of the eighteen genes
validated (Figure 5, Additional file 2: Table S3).
Discussion
The animal model generated in this study, is the first of
its kind. Two groups of heifers consistently divergent in
conception rate; HF and LF were successfully generated
and endometrial gene expression examined. We identi-
fied key genes and pathways potentially contributing to
endometrial related conception rate variance, the mostextreme of which had no previously known involvement
in endometrial function, including cellular growth and
proliferation NPPC and GJA1; angiogenesis MMP19 and
HMGB1; lipid metabolism FASN and PPARA; cellular and
tissue morphology and development FST and TGFB1I1;
inflammation IL-33; and metabolic exchange SLC1A3 and
SLC25A24.
Several studies have highlighted the vital role progester-
one plays in early embryo development to the extent that
decreased conception rates were observed in heifers with a
delayed postovulatory progesterone peak [60]. Furthermore,
it has been well documented that progesterone influences
endometrial and oviductal function [61,62]. In the present
study, progesterone concentrations were within the normal
range for both HF and LF heifers, and did not vary between
groups. In addition, CL diameter measurements were not
different between HF and LF animals and were consistent
with observations from other studies examining CL diame-
ters during this period of the estrous cycle [63]. The high
conception rates achieved across successive breedings
Table 5 Networks generated from endometrial gene expression data of HF versus LF heifers by IPA
Network ID Top functions Molecules in network Score Focus
molecules
1 Lipid Metabolism, Small Molecule Biochemistry ACTB, ADCY2, ADCY3, ANXA6, ARHGDIG, CACNB2, Calmodulin,
CNOT8, CTSL2, ERK, F Actin, FAU, FKBP7, FKBP10, FLNC, FSH,
GJA1, GUCY, hCG, IFI6, IL33, Lh, MARCKS (includes EG:4082),
NPPC, NR0B1, NTN4, Peptidylprolyl isomerase, PHLDA1, Pkc(s),
PPIH, Rock, RPLP1, RPLP2, SRD5A1, TP53I11
45 25
2 Cellular Growth and Proliferation, Connective
Tissue Development and Function, Skeletal and
Muscular System Development and Function
ACTA2, Alpha Actinin, CAT, CIAO1, COL1A2, Collagen type I,
Collagen(s), COPB2, CSRP1, CSRP2, CXCL2, ENPP1, FERMT2,
FHL2, FHL3, FST, G-Actin, GADD45B, GEFT, HSPB1, Integrin,
Laminin, LTBP1, MAGED1, MMP19, MYLK, NFkB (complex), Pak,
Pdgf, PJA1, RARRES2, RIT1, SERPINH1, Tgf beta, TGFB1I1
45 25
3 Carbohydrate Metabolism, Haematological
Disease, Metabolic Disease
26 s Proteasome, Akt, AMPK, EIF2C4, ELOVL5, FASN, GLUL,
HISTONE, Histone h3, Histone h4, HMG20B, Hsp90, MAP3K7IP2,
MED13, MED27, N-cor, ODC1, PPARA, PSMB10, PSMD2,
PSMD11, PTPRK, RAB3B, RBBP7, RCAN2, RPL23, RPS3, RPS5,
SFRP1, SMOC2, SOX6, SRPK2, T3-TR-RXR, Ubiquitin, UCP3
44 25
4 Cell Death, Gene Expression, Lipid Metabolism ACAT1, Caspase, CD58, CMPK1, ERK1/2, FUS, HMGB1 (includes
EG:3146), IFN Beta, IgG, IL1, IL12 (complex), IL6ST, ILF3,
IMPDH2, Insulin, Interferon alpha, Jnk, LDL, LGALS1, LGALS3,
LRAT, Mapk, Mek, NES, P38 MAPK, PCCB, PDGF BB, PI3K, PIBF1,
PRMT1, RABEP1, Ras, SLC25A12, STAT5a/b, TNIK
28 18
5 Cell Morphology, Inflammatory Response,
Lipid Metabolism
ARHGDIG, ARHGEF, ARHGEF11, CPS1, EMP3, ETFDH, FAU,
FNBP1, GLI3, IFI6, LARP1, LEP, Lpa receptor, P2RX7, Pka,
PLXNB2, PXN, RAGE, Ras homolog, RCN3, RGNEF, RHOH,
RHOU, RHPN1, RND2, RPL8, RPL26, RPL29 (includes EG:6159),
RPLP2, SCAMP2, St3gal, ST3GAL3, TNF, UCP3, YWHAZ
27 17
6 Drug Metabolism, Small Molecule Biochemistry,
Cell-To-Cell Signalling and Interaction
ABHD5, ALDH3A2, BAG3, BCL2, beta-estradiol, BIK, BOC,
C1QTNF6, CDON, CTNNB1, CTSH, CXADR, EEF2, F12, FOLH1,
GADD45B, GIMAP5, HOXC6, HSPB8, IFT122, IGFBP6, KCNMB1,
METTL7A, MME, MRVI1, PLIN2, PLIN5, PNPLA2, PTGIS, PTPRK,
PTPRU, SEMA5A, SFRP1, SULT1A1, SULT1A3
25 17
7 Embryonic Development, Organ Development,
Organ Morphology
Arginase, AZGP1, BMP6, C12ORF11, C19ORF10, C21ORF7,
CALM2, COL16A1, COL4A6, CSRP2, CTSH, CTSL2, DBNDD2,
DPYSL3, DYRK2, ENPP1, GOLGA7, HRAS, HTT, IFNG, IL13,
LPHN2, LRBA, LY6E, Pdgf, PLOD1, RAB12, RAB33A, SLC1A3,
SRM, SV2A, TCF12, TGFB1, UNC5B, ZDHHC9
23 15
8 Developmental Disorder, Neurological Disease,
Cell Death
ADAM10, AHCYL2, BCL2L14, CABC1, CORO2A, DUT (includes
EG:1854), ERH, F11R, GRPR, LETMD1, MAPK1, MARCKS (includes
EG:4082), MEST, NFATC2IP, NMB, NMBR, NMT1, NR3C1, PARK7,
PLK3, PMM1, PRKRA, PRPSAP1, REEP5, RNF144B, SH3D19,
SLC45A2, SMN1, SNUPN, SPOP, TP53, TRAF6, UBE2T,
ZNF259, ZNF346
22 15
9 Cellular Development, Cell Cycle, Connective
Tissue Development and Function
ABCD3, ACTC1, Actin, ATP13A5, ATP5J2, ATPase, CDKN2A,
CLPX, DDX19B, DONSON, FAM167A, GPHN, HIP1R, HLTF,
KATNA1, MED27, MIR373, MIR297-2, NCALD, NSF, ORC5L,
PACRGL, PHACTR1, phosphatidylinositol 3,4-diphosphate, PLS1,
POLR2H, RNA polymerase II, RSPO1, SDCCAG3 (includes
EG:10807), SNX16, SUOX, TBX3, TERT, TOB2, VIM
21 14
10 Post-Translational Modification, Cell Cycle,
Gene Expression
ACAA1B, CPT2, CUEDC2, DAP, EHHADH, ERBB2, ESR1, FRRS1,
GALNT1, GALNT2, GALNT3, GALNT6, HCG 2023776, IGFBP6,
LAMP1, LAMP2, MMS19, MRC1, MYC, NCOA4, OLFML3, PAICS,
PHF5A, Polypeptide N-acetylgalactosaminyltransferase, PPARG,
PTRF, QKI, RAB34, SCG5, SETDB1, SFRP1, STIM1, TPD52, WWC1
19 13
11 Cancer, Cardiovascular Disease, Cell-To-Cell
Signalling and Interaction
ALX1, APEH, C20ORF160, COPB2, COX2, COX4I1, DAG1, EPO,
FOS, GMFB, GRB2, GRP, GSTK1, GYLTL1B, HCLS1, HNRNPH2,
HNRNPR, Hydrolase, KHSRP, MST1R, ONECUT1, P2RY1, PDE6C,
PDE6G, POP7, RAB3GAP1, RCC2, RNF128, RPL7, RPS7, RPS18,
SMARCD2, TMEM62, USP8, YPEL5
19 13
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Table 5 Networks generated from endometrial gene expression data of HF versus LF heifers by IPA (Continued)
12 Embryonic Development, Tissue Development,
Tissue Morphology
ACOT13, APBB1, BACE1, C11ORF52, CBS, CELA1, Coup-Tf, DCK,
DKK1, DSC2, FOXA1, HMGB2, HNF4A, IER5L, JKAMP, KRR1, LRP,
LRP2, LRP5, LRP6, MESDC2, NR2F1, NR2F2, PARP4, PHB (in
cludes EG:5245), PKP2, Plasminogen Activator, POU5F1, RSPRY1,
Secretase gamma, SLC17A5, TXNDC12, UBE2D3
(includes EG:7323), UBE2V1, WNT4
19 13
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http://www.biomedcentral.com/1471-2164/15/234was indicative of reproductively healthy animals, with
good heat detection and insemination technique providing
confidence in retrospective fertility status. However, it is
important to note, other factors potentially contributing
to the conception rate differences observed between HF
and LF heifers, including oocyte quality and oviductal
environment, were not analysed in this study.
Endometrial function plays a critical role in pre-
implantation embryo survival. Consequently, much work
has focused on the biochemical and molecular phenom-
ena surrounding the progression of an estrous cycle
[27]. The present study is novel as it provides informa-
tion on gene expression during an important period of
the estrous cycle: the mid-luteal phase, otherwise recog-
nized as a critical period of embryo loss during pregnancy
[5,7] between animals of high and low reproductive cap-
acity. Reiterating the importance of examining transcrip-
tion during this phase, Salilew-Wondim et al. [31] recently
found more extensive differential gene expression in endo-
metrium harvested from heifers on D7 (an estrous cycleFigure 3 Network #1; lipid metabolism, small molecule biochemistry.
intensity indicates the expression of genes; with red representing up-regula
fold value is indicated under each node.prior to embryo transfer) between heifers that conceived
and those that returned to estrus before day 21, when
compared with D14.
GALNT6, encoding enzyme UDP-N-acetyl-alpha-D-gal
actosamine: polypeptide N-acetylgalactosaminyltransferase
6, was the most abundantly expressed gene in LF heifers. It
was 6.7 fold up-regulated in LF compared with HF heifers.
This is the first report of expression of this gene in Bos
taurus. The GALNT6 gene is located on chromosome
5 in the bovine genome and shares a coding region with
SLC4A8, a sodium bicarbonate co-transporter. Expres-
sion of this gene in humans is implicated in the synthesis
of oncofetal fibronectin (onfFN) [64], a protein found in
plasma and cervicovaginal secretions; increased concentra-
tions of which has been associated with abnormal preg-
nancy [65,66]. However, Feinberg et al. [67] reported
increased protein levels of onfFN at the trophoblast–endo-
metrial ECM interface in human pregnancy tissues from
gestational day 20 to full term in healthy pregnancies. These
observations suggest that differential expression of theThe network is displayed graphically as nodes (genes). The node color
tion and green, down-regulation in LF versus HF endometrium. The
Figure 4 Network #2; cellular growth and proliferation, connective tissue development and function, skeletal and muscular system
development and function. The network is displayed graphically as nodes (genes). The node color intensity indicates the expression of genes;
with red representing up-regulation and green, down-regulation in LF versus HF endometrium. The fold value is indicated under each node.
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vival and that this may be time specific however its role is
currently unclear.
Pathway analysis is widely used to analyze gene expres-
sion data and serves as an effective tool for delineating the
underlying biological processes involved in mRNA aberra-
tions [68-71]. Biological pathways altered in the current
study included: cellular growth and proliferation, lipid me-
tabolism, tissue remodeling, ECM mineralization, inflam-
mation, angiogenesis, and metabolic exchange.Cellular growth and proliferation
Owing to its regenerative nature, the endometrium under-
goes highly complex but tightly regulated cellular prolifera-
tion and differentiation throughout the estrous cycle [72].
There is little published information on the molecular
mechanism of bovine endometrial proliferation throughout
the estrous cycle however, studies examining uterine tissue
of non-pregnant ewes during cycle days 0 to 15 showed an
increased rate of cellular proliferation between days 0 and
4, decreasing by day 15, suggesting a proliferative dispos-
ition is normal earlier in the estrous cycle [73]. Results
from our study indicate that LF animals could be experien-
cing an abnormal decline in cellular growth/prolifera-
tion i.e. 21 genes implicated in cellular proliferation
inhibition, including FST [74], NPPC [75], GJA1 [76],
SOX6 [77], were up-regulated in the LF animals. Of
these genes FST, NPPC and GJA1 were previously foundto be expressed in bovine endometrial tissue [78,79].
Substantial inhibition of endometrial cellular proliferation
would retard the development of a secretory endometrium
and suppress endometrial maturation [80], thus making
successful implantation unlikely.Angiogenesis
A critical element of tissue growth and development is
the growth of new blood vessels, also known as angiogen-
esis [81]. Generally inactive in healthy individuals and ani-
mals, angiogenesis plays an active role in endometrial
function, as well as growth of ovarian follicles and CL dur-
ing the reproductive cycle [82,83]. In a highly proliferating
tissue such as endometrium, and particularly during
the hypothesized window of proliferation day 0 to 14/
15, angiogenesis is necessary for the provision of nutrients.
Factors controlling angiogenesis include growth factors,
nitric oxide and matrix metalloproteinases (MMPs), of
which MMP19 was down-regulated in the LF animals [84].
Also down-regulated, high-mobility group box 1 (HMGB1)
which codes for a protein which has previously been iden-
tified in uterine fluid of dairy heifers on day 7 post estrus
[22]. A role for members of the HMBG family in angiogen-
esis is supported by their expression during mouse em-
bryogenesis [85] with higher expression levels found in
proliferating cells [86] and lower expression in fibroblasts
from old-age humans [87]. Down-regulation of these and
other angiogenic genes, which was the case in LF animals,
Figure 5 Genes validated between RT-qPCR and microarray methodologies, including correlation coefficients (R) (n=12).
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with cellular proliferation that dominate the mid-luteal
phase [34].
Lipid metabolism
Lipid metabolism appears in three of the top 5 networks,
suggesting its importance as a metabolic process in uter-
ine physiology. Genes involved included ACAT1, CCAT,
LGALS1, PCCB, SRD5A1, FASN and PPARA. In particu-
lar, increased PPARA transcript abundance, as observed
in LF heifers, coincides with increased fatty acid catabol-
ism [88]. Fatty acids are essential precursors to steroids
and eicosanoids, metabolites necessary for normal ovar-
ian and uterine function [9]. Furthermore, studies have
shown fatty acid supplementation positively influences
reproductive performance [9,54].
Fatty acid synthase (FASN) exhibits its anabolic cap-
acity by aiding in the conversion of dietary carbohydrate
to fat, which is subsequently organized into hepatic adi-
pocytes and lactating mammary tissue as triglyceride and
milk lipids, respectively [89,90]. It has also been found that
expression of FASN peaks during the proliferative phases
of the menstrual cycle [91]. Metabolic demands are par-
ticularly high during this phase as a result of the exten-
sive endometrial remodeling and reconstruction, a central
theme to both the estrous and menstrual cycles. Increased
FASN would be favorable in such a demanding situation to
deliver the required fatty acid for the assembly of new cell
membranes, modification of DNA transcriptional machin-
ery and hormone construction. Interestingly, expression of
FASN was down-regulated in the LF heifers suggesting the
aforementioned processes were compromised in these ani-
mals, which potentially affecting their ability to conceive.
Steroid 5α-reductase type 1 enzyme is involved in the
metabolism of progesterone that is found in uterine and
cervical cavities. Murine gene knock-out studies have
shown that parturition is adversely affected by aberrant
expression of this gene, impeding cervical ripening and
fetal delivery as a result of elevated progesterone levels
in the cervix [92]. Expression of the gene coding for this
enzyme was up-regulated in LF heifers, thus progester-
one catabolism is likely to be active in these animals. As
high progesterone levels are positively associated with
embryo survival [60,93], it is therefore possible that the
LF animals are experiencing low local progesterone con-
centrations and ultimately, this could be contributing to
their low conception rates.
Cellular and tissue morphology and development
The ability of cells to generate alternate cell types whose
phenotype is different from that of the source tissue is
known as plasticity. Endometrial epithelial and stromal cell
proliferation, as discussed previously, is a complex multi-
component process involving cues from extra-cellulargrowth factors and ovarian hormones [72,94]. However, in
their absence, isolated bovine endometrial stromal cells
exhibit the ability to develop into bone [95]. Results from
our microarray study showed a large representation from
this biological category, with 36 DEG enriched. Genes im-
plicated in cell and tissue morphology and development
which were down-regulated in low fertility heifers in-
cluded, PPARA, IL6ST, GJA1, SFRP1 and IL-33.
One particular biochemical pathway which facilitates
cellular transformation includes extracellular matrix
mineralization (ECM) [96]. A well known regulator of
ECM mineralization is the activin a-FST system. Activin
A inhibits ECM mineralization whereas FST, an activin
antagonist which prevents activin-receptor interaction
[97], increases mineralization in cell cultures [98]. Trans-
genic female mice with gain-of-function FST, in which
mouse follistatin was over-expressed, developed thin uteri
and small ovaries, resulting in infertility [99]. FST was dif-
ferentially expressed between HF and LF heifers, indicat-
ing a role for this gene pathway in mid-luteal endometrial
homeostasis and early embryo survival.
ECM remodeling, occurring during both pregnancy and
the estrous cycle, facilitated by the matrix-metalloprotei
nases, ensures the provision of a suitable structural micro-
environment where the embryo can grow [100,101].
Matrix-metalloproteinase-19 (MMP-19), an important
molecule in this pathway and which was down-regulated
in LF heifers, plays a significant role in ECM remodelling
[102]. Interestingly, Wathes et al. [103] reported that dif-
ferential expression of genes MMP - 1, 2, 3, and 13 two
week post partum in the bovine endometrium, was highly
correlated with differential expression of IGF binding pro-
tein 4, a known antagonist of IGF1 expression [104]. The
IGF system, in particular IGF1, is associated with several
reproductive processes in cattle including preimplantation
embryo development [105-107].
The transforming growth factor βs (TGF-β) are multi-
functional cytokines that also regulate tissue remodelling
and repair [108,109]. High expression of TGF-β has been
observed during pro-estrus and diestrus [110,111] thereby
highlighting the role for TGF-βs in endometrial remodel-
ling, an important process impeding estrous cycle transi-
tion [112]. Transforming growth factor beta 1 induced
transcript (TGFB1I1) was down-regulated in the LF ani-
mals, suggesting altered or irregular endometrial remodel-
ling in these animals which may be contributing to the
conception rate differences observed between the two di-
vergent fertility groups.
Inflammation
Inflammation is an innate cyclical physiological process
facilitating progression of reproductive cycles in the endo-
metrium. The animal model in this study isparticularly
useful for the identification of inflammatory pathways
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Firstly, there has been no mitogenic challenge. This study
strictly examines gene expression between high and low
conception rate animals without influence from any ex-
ogenous metabolites, either dietary or pharmaceutical. Sec-
ondly, tissue sampling occurred during an estrous cycle
where no embryo was present. Lastly, the study employed
nulliparous heifers where the likelihood of uterine infection
is low, as was demonstrated by the lack of clinical evidence
of metritis, endometritis, pyometra or metaplasia across all
heifers examined.
In total 55 DEG featured in inflammatory linked path-
ways. It is clear from the high proportion of DEG that in-
flammation is a central theme in estrous cycle and uterine
sub-fertility physiology. IL-33, a cytokine which influences
the production of other pro-inflammatory cytokines IL-5,
IL-13 and chemokine GM-CSF [113] was more highly
expressed in LF animals. In addition, IL-33 regulates tran-
scription of endothelial cells in inflamed rheumatic tissues
[114]. As mentioned previously, cell plasticity is altered in
a state of chronic inflammation or trauma. Inflammation
due to up-regulated IL-33 could be altering the constitu-
tion of the endometrium in the LF animals, and thus im-
peding embryo implantation. Hence, low conception rates
could be directly linked to inflammation induced, altered
cellular plasticity, in uterine endometrial tissues.Metabolic exchange
Similar to Forde et al. [33], Bauersachs et al. [29] and
Salilew-Wondim et al. [31], genes coding metabolite trans-
porters, specifically the solute carrier (SLC) family mem-
bers were found to be differentially expressed between HF
and LF animals. The five SLC genes identified were;
SLC1A3, SLC17A5, SLC25A12, SLC25A24, SLC45A2. The
most abundantly expressed gene of the entire DEG list,
SLC45A2, was 8-fold more highly expressed in the uterus
of LF relative to HF heifers. As the name suggests SLC
genes are involved in the transfer of solutes across the
cell membrane, particularly amino acids [115-117]. Amino
acids are fundamental for the normal growth and develop-
ment of the early embryo, acting as precursors of nucleic
acids and proteins, osmolytes and signaling molecules.
Concentrations of amino acids in oviductal and uterine
fluid during the estrous cycle have been reported to modu-
late with stage of cycle, systemic progesterone environment
and differ compared with plasma, demonstrating their ac-
tive transport in these tissues [118-121]. The endometrium
functions as a secretory layer, suggesting the importance of
metabolite exchange in this specific tissue. Animals with
less efficient metabolic exchange in the uterus may be
unable to sustain embryo development during early
pregnancy, and thus be experiencing recurring early
embryo loss.Microarray analysis was carried out on endometrial
tissue, an amalgam of varying cell types. Examining tis-
sue mRNA gene expression provides an insight into the
genetic regulation of multiple cell types from the host. It
was essential to use RNA from all endometrial cell types
as it is not apparent, as of yet, whether or which individ-
ual endometrial cell types are contributing to low con-
ception rates in cattle. Investigations into the types and
locations of contributing cell types via in situ hybridisa-
tion or immunofluorescence would assist in the develop-
ment of proposed hypotheses.
Conclusion
Global endometrial gene expression profiles during the
mid-luteal phase of the estrous cycle, in HF and LF heifers
was investigated, and the most significant biological path-
ways likely to be involved in uterine function and embryo
survival identified. The new knowledge generated offers
substantial insight into some of the molecular mecha-
nisms underlying uterine endometrial function and uter-
ine mediated low-fertility, during the early to mid luteal
phase of the estrous cycle in cattle. Furthermore, expres-
sion analysis provides invaluable data on key differentially
expressed genes which may be selected for future SNP
discovery analysis which following validation may be used
as genetic markers for fertility and incorporated into
breeding programmes.
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